Skip to main
OHI

OHI Stock Forecast & Price Target

OHI Analyst Ratings

Based on 8 analyst ratings
Buy
Strong Buy 25%
Buy 25%
Hold 50%
Sell 0%
Strong Sell 0%

Bulls say

Omega Healthcare Investors Inc. has raised its 2025 funds from operations (FFO) estimate to $2.81 per share from $2.78 per share, demonstrating stronger investment volume than previously anticipated. Additionally, the company's normalized FFO estimate has also been increased to $2.95 per share, up from $2.89 per share, after excluding certain non-recurring items, indicating improved operational stability. Furthermore, the stock is performing well with a year-to-date increase of 12%, outperforming the VNQ index, and currently trades near the higher end of its 10-year valuation range, suggesting robust market confidence.

Bears say

Omega Healthcare Investors Inc. faces ongoing operational challenges, which contribute to a negative outlook on the stock, emphasized by the company's current relative valuation. Although adjusted Funds From Operations (FFO) estimates for 2026 show a modest increase to $3.22 per share, this figure surpasses the consensus core FFO estimate of $3.10 per share, indicating a troubling disconnect between growth expectations and current market conditions. The persistent difficulties faced by operators within the healthcare facility sector further complicate the investment landscape, adding to concerns regarding the stability and profitability of Omega's core business model.

OHI has been analyzed by 8 analysts, with a consensus rating of Buy. 25% of analysts recommend a Strong Buy, 25% recommend Buy, 50% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Omega Healthcare Investors and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Omega Healthcare Investors (OHI) Forecast

Analysts have given OHI a Buy based on their latest research and market trends.

According to 8 analysts, OHI has a Buy consensus rating as of Dec 30, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $46.62, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $46.62, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Omega Healthcare Investors (OHI)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.